Company Update Senores Pharmaceuticals Ltd - 544319 - Disclosure Under Regulation 30 Of The Securities And Exchange Board … BSE India Senores Pharmaceuticals Limited has informed the Exchange regarding updates on USFDA Inspection at Havix Group Inc. d/b/a Aavis Pharmaceuticals, material subsidiary of the Company